← Back to Search

Behavioral Interventions for Body Dysmorphic Disorder (BDD Trial)

Phase 2
Waitlist Available
Led By Eda Gorbis, PhD, LMFT
Research Sponsored by Westwood Institute for Anxiety Disorders, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18-60
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 and at 1 month
Awards & highlights

BDD Trial Summary

This trial is testing two different exposure therapies to treat Body Dysmorphic Disorder, a condition where sufferers worry excessively about some flaw in their appearance that may be minimal or nonexistent. The goal is to determine the efficacy of exposure therapy that utilizes mirrors in the treatment of BDD.

Who is the study for?
This trial is for adults aged 18-60 with Body Dysmorphic Disorder (BDD), as defined by the DSM-IV, who are English-speaking and have not changed their psychotropic medication recently. They must score above certain thresholds on BDD-specific assessments. People with primary OCD, depression, substance abuse issues or other psychiatric conditions like psychosis or bipolar disorder cannot join.Check my eligibility
What is being tested?
The study compares two behavioral interventions for BDD: Mirror Retraining Method and Crooked Mirror Externalization Therapy. Participants will undergo three weeks of cognitive-behavioral therapy paired with one of these mirror-based techniques to see which is more effective at reducing BDD symptoms.See study design
What are the potential side effects?
Since the interventions are behavioral therapies involving mirrors and do not involve drugs or medical procedures, there are no typical side effects like those seen in drug trials. However, participants may experience emotional discomfort during treatment.

BDD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 60 years old.

BDD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 and at 1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 and at 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Measure of change in the presence and severity of BDD before and after treatment
Secondary outcome measures
Measure of change in the presence and type of BDD symptoms before and after treatment

BDD Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Crooked Mirror Externalization TherapyExperimental Treatment1 Intervention
Of recent, the "crooked mirror" externalization therapy, developed by Dr. Eda Gorbis, has been put to use with much success (Gorbis 2004). This method involves the use of crooked or "fun house" mirrors made from highly reflective surfaces that can be bent in different directions, which distort and exaggerate the patient's perceived defects (Gorbis 2005). In turn, this process externalizes or reverses the patient's internalized distorted body image, and allows the patient to habituate to the reflection of the imagined defect that is even more distorted than the internalized image (Rosen et al. 1995).
Group II: Mirror Retraining MethodActive Control1 Intervention
In treating BDD, the cognitive-behavioral technique, "mirror retraining," uses ordinary and/or magnifying mirrors to amplify the supposed defect, which teaches patients to see their appearance in a more holistic way. Since BDD patients tend to only focus on their perceived flaws when looking in the mirror, and tend to think about their flaws in negative terms, in mirror retraining, patients learn how to change their negative evaluations of their appearance into more objective and nonjudgmental descriptions. Generally, this method is designed to intentionally exaggerate anxiety regarding appearance concerns through exposures with mirrors. However, using exclusively ordinary and/or magnifying mirrors does not address the internal distorted image that many patients with BDD experience (Rosen et al. 1995, Osman et al. 2004, Veale 2004).

Find a Location

Who is running the clinical trial?

Westwood Institute for Anxiety Disorders, IncLead Sponsor
Eda Gorbis, PhD, LMFTPrincipal InvestigatorUCLA - DEPARTMENT OF PSYCHIATRY/BIOBEHAVIORAL SCIENCES

Media Library

Crooked Mirror Externalization Therapy Clinical Trial Eligibility Overview. Trial Name: NCT01316627 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies in this experiment for test subjects?

"The clinical trial described is no longer active, however there are 12 other studies currently recruiting patients."

Answered by AI

What are the risks associated with Crooked Mirror Externalization Therapy?

"Crooked Mirror Externalization Therapy is a Phase 2 trial, which means that while there is some safety data, none of it supports efficacy. As such, our team at Power have given it a score of 2."

Answered by AI
~1 spots leftby Apr 2025